Annual Study of Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2005-2006 Formulation)
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 12 Jun 2009 Inclusion and exclusion criteria amended from NCT.
- 22 Sep 2008 Sanofi Pasteur added as an affiliate as reported by ClinicalTrials.gov.
- 22 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.